NCT06838702

Brief Summary

Observational cohort study offered consecutively to every liver transplant patient who arrives for the first endocrinology visit or returns for follow-up visit for bone metabolism assessment.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
19mo left

Started Jan 2023

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress69%
Jan 2023Jan 2028

Study Start

First participant enrolled

January 11, 2023

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

December 3, 2024

Completed
3 months until next milestone

First Posted

Study publicly available on registry

February 21, 2025

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 10, 2028

Expected
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 11, 2028

Last Updated

February 21, 2025

Status Verified

November 1, 2024

Enrollment Period

5 years

First QC Date

December 3, 2024

Last Update Submit

February 19, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Bone Mass in Liver Transplant Patients

    Evaluation of bone mass in patients undergoing liver transplantation followed at the Endocrinology Operating Unit for Bone Mineral Metabolism, through the creation of a structured data collection in which to census all cases diagnosed and evaluated since 1/1/2009 at the U.O. Endocrinology of the S. Orsola-Malpighi Polyclinic. For the prospective phase, the expected duration of individual patient observation is 5 years

    through study completion, an average of 4 years

  • Calcium Metabolism Indices in Liver Transplant Patients

    Evaluation of laboratory values related to calcium metabolism in patients undergoing liver transplantation, specifically focusing on blood levels of calcium, phosphate, parathyroid hormone (PTH), and vitamin D. These parameters will be assessed using standard laboratory tests conducted at the Endocrinology Operating Unit for Bone Mineral Metabolism. Data will be collected through a structured registry that includes all cases diagnosed and evaluated since 1/1/2009 at the U.O. Endocrinology of the S. Orsola-Malpighi Polyclinic.

    through study completion, an average of 4 years

  • Fracture Incidence in Liver Transplant Patients

    Evaluation of fracture incidence in patients undergoing liver transplantation in patients undergoing liver transplantation followed at the Endocrinology Operating Unit for Bone Mineral Metabolism, through the creation of a structured data collection in which to census all cases diagnosed and evaluated since 1/1/2009 at the U.O. Endocrinology of the S. Orsola-Malpighi Polyclinic. For the prospective phase, the expected duration of individual patient observation is 5 years

    through study completion, an average of 4 years

Secondary Outcomes (2)

  • Prevalence of Fractures in Patients Undergoing Liver Transplantation

    through study completion, an average of 4 years

  • Relationship Between Biochemical Parameters and Bone Mineral Density (BMD) Trends in Liver Transplant Patients

    through study completion, an average of 4 years

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients undergoing liver transplantation and followed at the Endocrinology Operating Unit for bone mineral metabolism.

You may qualify if:

  • Age \>18 years
  • Patients undergoing liver transplantation for any cause.
  • Performance of bone densitometry
  • Performance of examinations pertaining to mineral metabolism
  • Obtaining informed consent

You may not qualify if:

  • none

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Bologna, Bologna, 40138, Italy

RECRUITING

MeSH Terms

Conditions

Osteoporosis

Condition Hierarchy (Ancestors)

Bone Diseases, MetabolicBone DiseasesMusculoskeletal DiseasesMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • Uberto Pagotto, MD

    IRCCS Azienda Ospedaliero-Universitaria di Bologna

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Uberto Pagotto, MD

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Target Duration
5 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 3, 2024

First Posted

February 21, 2025

Study Start

January 11, 2023

Primary Completion (Estimated)

January 10, 2028

Study Completion (Estimated)

January 11, 2028

Last Updated

February 21, 2025

Record last verified: 2024-11

Locations